首页 › 基金 › Lightspeed Management Company, L.L.C. › OLMA

Lightspeed Management Company, L.L.C. 对 OLMA 的持仓历史

OLEMA PHARMACEUTICALS INC · 医疗保健

Lightspeed Management Company, L.L.C. 在 Q3 2026 的 13F 申报中披露持有 OLMA(OLEMA PHARMACEUTICALS INC)1,355,299 股,市值约 US$11.7M,约占其申报组合的 0.58%,在其申报持仓中市值排名第 6 位。 Lightspeed Management Company, L.L.C. 最近 8 个申报季度中有 8 个季度披露了 OLMA 持仓,最早可追溯至 Q4 2024。

最新持仓 (Q3 2026)1.36M 股
申报持仓市值$11.71M
组合权重0.58%
首次申报Q4 2024
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Lightspeed Management Company, L.L.C. 对 OLMA 的持仓演变

Lightspeed Management Company, L.L.C. 于 Q4 2024 首次披露 OLMA 持仓:1,930,894 股(约 US$11.3M)。 该持仓在 Q4 2025 达到峰值 1,930,894 股,市值约 US$48.3M。 在 8 次申报中,Lightspeed Management Company, L.L.C. 0 次增持、1 次减持、6 次保持不变。 最近一期申报(Q3 2026)显示持股 1,355,299 股、市值约 US$11.7M。 持仓曾出现大幅变动:Q1 2026 减持约 30% (随后一个季度股价下跌 16%)。

逐季持仓明细

季度股数金额变化
Q4 2024 1.93M $11.26M 新进
Q1 2025 1.93M $7.26M 持有
Q2 2025 1.93M $8.23M 持有
Q3 2025 1.93M $18.90M 持有
Q4 2025 1.93M $48.27M 持有
Q1 2026 1.36M $20.21M 减持
Q2 2026 1.36M $16.95M 持有
Q3 2026 1.36M $11.71M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 OLMA 与 13F 数据

OLMA(OLEMA PHARMACEUTICALS INC)属于医疗保健行业。我们追踪的基金中还有 36 只申报持有 OLMA,申报仓位最大的包括:Paradigm Biocapital Advisors LP (US$108.5M), Bain Capital Life Sciences Investors, LLC (US$88.6M), BVF INC/IL (US$66.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 OLMA 的基金

查看 OLMA 的全部基金持有人 →

常见问题

How long has Lightspeed Management Company, L.L.C. held OLMA?

Lightspeed Management Company, L.L.C. has disclosed OLMA holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Lightspeed Management Company, L.L.C.'s current position in OLMA?

As of Q3 2026, Lightspeed Management Company, L.L.C. holds 1.36M shares of OLMA (OLEMA PHARMACEUTICALS INC), valued at $11.71M, representing 0.58% of its reported portfolio and ranking #6.

Has Lightspeed Management Company, L.L.C. been buying or selling OLMA?

In the latest 13F filing (Q3 2026), Lightspeed Management Company, L.L.C. held unchanged its position in OLMA. The position peaked in Q4 2025 at 1.93M shares.

Which other funds hold OLMA?

Other major institutional holders of OLMA include Paradigm Biocapital Advisors LP, Bain Capital Life Sciences Investors, LLC, BVF INC/IL, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.